NCT00972530

Brief Summary

BACKGROUND: Intra-articular glucocorticoid injections are frequently used to relieve symptoms of arthritis. Postinjection rest has been shown to improve the outcome of knee joint injections, but not for wrist injections. Consequently, different joints respond differently on postinjection regimens. OBJECTIVES: To investigate whether better treatment results might be achieved of post-injection rest following intra-articular glucocorticoid treatment for elbow synovitis. METHODS: 90 patients with rheumatoid arthritis (RA) and elbow synovitis were treated with 20 mg intra-articular triamcinolone hexacetonide and randomised to either a 48 hour immobilisation in a triangular sling (n=46) or normal activity without restrictions (n=44). Primary endpoint was relapse of synovitis. In addition, pain, function according to a self assessment questionnaire (PREE) and range of movement were followed for six months.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Jan 2006

Typical duration for not_applicable rheumatoid-arthritis

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 7, 2009

Completed
2 months until next milestone

Results Posted

Study results publicly available

November 11, 2009

Completed
Last Updated

March 14, 2019

Status Verified

October 1, 2009

Enrollment Period

2.9 years

First QC Date

September 3, 2009

Results QC Date

September 10, 2009

Last Update Submit

February 18, 2019

Conditions

Keywords

rheumatoid arthritistreatment

Outcome Measures

Primary Outcomes (1)

  • Relapse of Arthritis

    The patients were followed for six months and if signs and symptoms recurred in between the patients were told to contact the rheumatology department. In such cases the elbow was re-examined and if a relapse could be confirmed the duration of effect was recorded and if needed the patient was offered another injection.

    Regular visits at one week, 3 months and 6 months.

Study Arms (2)

Activity

NO INTERVENTION

Normal activity without restrictions

immobilisation

ACTIVE COMPARATOR

48 hours postinjection rest

Behavioral: immobilisation in a triangular sling

Interventions

Intervention group: Immobilisation 48 hours in a triangular sling (mitella) Control group: normal activity without restrictions

Also known as: Postinjection rest, normal joint usage
immobilisation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Rheumatoid arthritis, and
  • Clinical signs of elbow synovitis

You may not qualify if:

  • Patients in function class 4 according to Steinbrocker as well as patients with oral glucocorticoid treatment corresponding to more than 7.5 mg prednisolone or intra-articular treatment in the joint the past three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Weitoft T, Forsberg C. Importance of immobilization after intraarticular glucocorticoid treatment for elbow synovitis: a randomized controlled study. Arthritis Care Res (Hoboken). 2010 May;62(5):735-7. doi: 10.1002/acr.20039.

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Immobilization

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Results Point of Contact

Title
Dr Tomas Weitoft
Organization
Department of Research and Development County Council of Gavleborg/Uppsala University

Study Officials

  • Tomas Weitoft, MD PhD

    Department of Research and Development County Council of Gävleborg/Uppsala University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2009

First Posted

September 7, 2009

Study Start

January 1, 2006

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

March 14, 2019

Results First Posted

November 11, 2009

Record last verified: 2009-10